ZHEJIANG STARRY PHARMACEUTICAL CO revenue breakdown overview

ZHEJIANG STARRY PHARMACEUTICAL CO revenue for the last year amounted to 2.35 B CNY, the most of which — 1.87 B CNY — came from its highest performing source at the moment, Contrast Agent, the year earlier bringing 1.82 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought ZHEJIANG STARRY PHARMACEUTICAL CO 1.23 B CNY, and the year before that — 1.21 B CNY.